tipo
- journal article
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
Documento
- doi:10.1186/s13287-022-02796-1
- http://dx.doi.org/10.1186/s13287-022-02796-1
- http://https://link.springer.com/epdf/10.1186/s13287-022-02796-1?sharing_token=hdeAFv9Tabd12Btgufgoz2_BpE1tBhCbnbw3BuzI2ROPU88uOlAPuMd2mJEgwFekEK5kTSaCXNdXSBZljZR0MIp5TtzzL_ySLdSQ4U4GoPBtNqvJdCR3GVgzZoe_gArImbHKEfc_cgbjs0jEtS9dfQWNMeO1KlWj63IhUU3nSRI%3D][doi:10.1186/s13287-022-02796-1
- Visão geral
- Pesquisas
- Identidade
- Informação adicional documento
- Outro
- Ver todos